|
W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER
|
Back to Search Results |
|
| Catalog Number |
DSF2433 |
| Medical Device Problem Code |
Patient Device Interaction Problem (4001)
|
| Health Effect - Clinical Code |
Vascular Dissection (3160)
|
| Date of Event |
09/03/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
The following information was reported to gore: on (b)(6), 2025, the patient underwent endovascular treatment for an aortic arch aneurysm using the gore® dryseal flex introducer sheath (dsf), and gore® tag® conformable thoracic stent graft with active control system (ctag), and the non-gore stent grafts.When the dsf was inserted via the right femoral artery, resistance was encountered at a stenotic segment of the right external iliac artery.After deployment of the non-gore stent graft (zenith), while delivering the ctag, the zenith migrated.A touch-up of the zenith was performed, and the ctag was successfully deployed.After all stent grafts were deployed, a retrograde dissection was observed from the right external iliac artery to the right common iliac artery.A non-gore stent (misago) was placed at the dissection site, and the disappearance of the false lumen was confirmed.Physician¿s comment the area was calcified, and part of the lumen measured approximately 6 mm, which raised concerns about access.
|
| |
|
Search Alerts/Recalls
|
|
|